Severe chronic spontaneous urticaria in children – treatment options according to the guidelines and beyond – a 10 years review

Abstract

When omalizumab therapy including up-dosing strategies or shortened interval shows no symptom improvement, alternative therapies, sometimes off-label have to be considered in time.